Cepheid (CPHD) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts CPHD Hot Sheet
Price: $52.95 --0%
Financial Fact:
Foreign currency exchange loss and other: -1.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Foreign currency exchange loss and other: -1.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cepheid (NASDAQ: CPHD) reported Q2 EPS of ($0.06), $0.15 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $132.5 million versus the consensus estimate of $130.7 million.
For earnings history and earnings-related data on Cepheid (CPHD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Braze stock tumbles 10% on weak third quarter EPS guidance
- Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
